ARCHIVES

Drug Development: FDA Grants Breakthrough Therapy Designation to CTL019 In ALL

This article is from The Cancer Letter archive.

Vol. 40 No. 28 | July 11, 2014

Download PDF Visit The Full Archive

Related Articles

New Biologic Modalities Show Promise In Treatment Of Lymphomas, Research Finds

June 28, 2002

Medenica Trial Begins In South Carolina

February 10, 1995

FASEB Delivers Its Recommendations For Federal Research Funding in 2013

February 3, 2012

Questions Raised By Committee Kills Still Not Resolved

July 29, 1977

NIH Study Confirms Male Risk Factors For Breast Cancer

February 28, 2014

NCAB To Hear Details Of New Grant Program, Hanna’s Frederick Plans

November 15, 1974